메뉴 건너뛰기




Volumn 22, Issue 22, 2003, Pages 3441-3451

A deletion mutant of heregulin increases the sensitivity of breast cancer cells to chemotherapy without promoting tumorigenicity

Author keywords

Antiestrogen resistance; Breast cancer; Doxorubicin; Drug resistance; Estrogen dependence; HRG; Mutants

Indexed keywords

DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ETOPOSIDE; MITOGEN ACTIVATED PROTEIN KINASE; NEU DIFFERENTIATION FACTOR; RECEPTOR PROTEIN; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

EID: 0038118346     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206410     Document Type: Article
Times cited : (16)

References (27)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.